United States: The overall number of deaths of young women from cervical cancer in the US is dropping rapidly, and health experts believe it is all down to one vaccine.
Cervical cancer deaths in women under the age of 25 have reduced by sixty-two percent, according to the national health data over the last decade alone.
More about the news
Gardasil vaccine is behind the dramatic shift reveals the senior author, Ashish Deshmukh, of the Medical University of South Carolina, US.
Additionally, the clinical trials performed in the UK and Australia have also revealed the fact that cervical cancer incidence is rapidly decreasing among women who took the medicine, sciencealert.com reported.
The Gardasil multi-dose vaccine was licensed for young girls in the US in 2006 to eliminate deadly types of the human papillomavirus (HPV).
About the prevalence of deadly HPV
HPV is a skin-to-skin contact transmitted vaccine-preventable infection, and it is also responsible for 70 percent of invasive cervical cancers that rank as one of the top causes of cancer deaths among American women.
Although cervical cancer is very limited in young women, the vaccine is now making cases under 25 even fewer, according to new studies.
The national health data shows that the first cohorts of girls in the US who could receive the HPV vaccine (who were about 10 at the time) were at least 30 percent less likely than their counterparts to die from cervical cancer before turning 25.
A survey done on previous research in the US reveals that cervical cancer cases have declined by 65 percent among women below the age of 25 years in the period between 2012 and 2019.
However, this is the first paper to examine death rates from those patients, sciencealert.com reported.
To conduct the study, health statistics of females below 25 years of age from 1992 to 2021 were grouped in three-year intervals.
The cervical cancer death rate of young women in the US between 1992 and 1994 stands at 55 cervical cancer deaths per 100,000 cervical cancer deaths.
Between 1992 and 1994, the US experienced 55 young cervical cancer deaths per 100,000 people.